Pathogenic LoF variants in CDKL5 cause CDKL5‐deficiency disorder (CDD), an X‐linked disorder primarily affecting females and characterized by early onset refractory epilepsy, hypotonia, developmental delay, intellectual disability and visual impairment (Olson et al., 2019). Here, CDKL5 is linked to craniodiaphyseal dysplasia.